Bone Mineral Density Screening Among Women with a History of Breast Cancer Treated with Aromatase Inhibitors

BACKGROUND: Understanding adherence to bone mineral density (BMD) screening after breast cancer (BC) treatment with aromatase inhibitors (AI) is an important first step in preventing or treating BC-related osteoporosis. METHODS: This retrospective cohort study assessed receipt and adherence to BMD s...

Full description

Saved in:
Bibliographic Details
Main Authors: Spangler, Leslie, Yu, Onchee, Loggers, Elizabeth, Boudreau, Denise M.
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc. 2013
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573722/
https://ncbi.nlm.nih.gov/pubmed/23362883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jwh.2012.3687
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items